Following U.S. Stocks are trending during the current trade: RSP Permian Inc (NYSE:RSPP), Comerica Incorporated (NYSE:CMA), Pernix Therapeutics Holdings Inc (NASDAQ:PTX), FXCM Inc (NYSE:FXCM)
Their insights are depicted underneath:
RSP Permian Inc (NYSE:RSPP)’s shares picked up 5.41%, and is now trading at $29.82.
According to PRNewswire, RSP Permian, Inc. (RSPP), declared it has changed the date it will release its fourth quarter and full-year 2014 results to Tuesday, March 17, 2015, before the New York Stock Exchange opens. This release will be followed by a conference call at 10:00 Central Time (11:00 a.m. Eastern Time) to talk about RSP’s fourth quarter and full-year 2014 results. Hosting the call will be Steve Gray, Chief Executive Officer, Scott McNeill, Chief Financial Officer and Zane Arrott, Chief Operating Officer.
RSP is an independent oil and natural gas corporation focused on the attainment, exploration, development and production of unconventional oil and associated liquids-rich natural gas reserves in the Permian Basin of West Texas.
Comerica Incorporated (NYSE:CMA), declined -0.13%, and is now trading at $47.03.
According to PRNewswire, Comerica Incorporated (CMA), declared that it has stated its 2015 corporation-run stress test results, as required under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. The information is accessible in the Investor Relations section of Comerica’s website at investor.comerica.com, on the “Dodd-Frank Act Stress Test Results” page under “Financial Reports.”
Comerica Incorporated is a financial services corporation headquartered in Dallas, Texas, and planned ally aligned by three business segments: The Business Bank, The Retail Bank, and Wealth Administration. Comerica focuses on relationships, and assisting people and businesses be successful. In addition to Texas, Comerica Bank locations can be found in Arizona, California, Florida and Michigan, with select businesses operating in several other states, in addition to in Canada and Mexico.
Pernix Therapeutics Holdings Inc (NASDAQ:PTX), enhanced 0.85%, and is now trading at $11.88, hitting new 52-week high of $12.10.
Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical corporation, declared that Sanjay Patel, Chief Financial Officer, presented an update on the corporation at the Cowen and Corporation Health Care Conference in Boston, MA on March 3rd.
Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Corporation targets underserved therapeutic areas such as CNS, counting neurology and psychiatry, and has an interest in expanding into additional specialty segments. The Corporation promotes its branded products to physicians through its Pernix sales force, uses contracted sales organizations to market its non-core, cough and cold products, and markets its generic portfolio through its wholly owned auxiliaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.
FXCM Inc (NYSE:FXCM), dwindled -4.63%, and is now trading at $2.06.
According to GLOBE NEWSWIRE, on February 19, FXCM Inc. (FXCM), declares that for a limited time, it will be offering its best products and resources for free without commitment. FXCM has long believed in offering its clients all the right tools to assist them succeed, with an emphasis on trading education. DailyFX, FXCM’s news, research and education website, has assisted participants navigate the FX and CFD markets through a comprehensive suite of educational services.
FXCM Inc. (FXCM) is a global online provider of foreign exchange (forex) trading and related services to retail and institutional customers world-wide.
At the heart of FXCM’s client offering is No Dealing Desk forex trading. Clients benefit from FXCM’s large network of forex liquidity providers enabling FXCM to offer competitive spreads on major currency pairs.
